| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 45.796 | 0 | 0 | - | - | - | - | - | - | - |
| Total Income - EUR | 45.796 | 0 | 0 | - | - | - | - | - | - | - |
| Total Expenses - EUR | 12.106 | 9.340 | 812 | - | - | - | - | - | - | - |
| Gross Profit/Loss - EUR | 33.691 | -9.340 | -812 | - | - | - | - | - | - | - |
| Net Profit/Loss - EUR | 32.317 | -9.340 | -812 | - | - | - | - | - | - | - |
| Employees | 2 | 1 | 0 | - | - | - | - | - | - | - |
Check the financial reports for the company - Best Pharm Inovation Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 132.937 | 156.997 | - | - | - | - | - | - | - |
| Current Assets | 76.262 | 27.424 | 15.367 | - | - | - | - | - | - | - |
| Inventories | 0 | 0 | 0 | - | - | - | - | - | - | - |
| Receivables | 76.112 | 27.274 | 15.351 | - | - | - | - | - | - | - |
| Cash | 150 | 151 | 16 | - | - | - | - | - | - | - |
| Shareholders Funds | 51.017 | 41.157 | 39.648 | - | - | - | - | - | - | - |
| Social Capital | 45 | 45 | 44 | - | - | - | - | - | - | - |
| Debts | 25.245 | 119.204 | 132.716 | - | - | - | - | - | - | - |
| Income in Advance | 0 | 0 | 0 | - | - | - | - | - | - | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "113 - 113" | |||||||||
| CAEN Financial Year |
113
|
|||||||||
Comments - Best Pharm Inovation Srl